![Membrane technology / Kidney diseases / Erythropoietin / Dialysis / Peginesatide / Chronic kidney disease / Robert Provenzano / Home hemodialysis / Medicine / Nephrology / Renal dialysis Membrane technology / Kidney diseases / Erythropoietin / Dialysis / Peginesatide / Chronic kidney disease / Robert Provenzano / Home hemodialysis / Medicine / Nephrology / Renal dialysis](https://www.pdfsearch.io/img/b2c988881b5227ff5a4755876f07b03c.jpg)
| Open Document File Size: 1,49 MBShare Result on Facebook
Company Regulatory Affairs Affymax Inc. / MD Affymax Inc. / EPO / Affymax Inc. / PharmD Affymax Inc. / / Event FDA Phase / / Facility Wayne State University / / IndustryTerm treatment of anemia associated with chronic kidney disease / / MedicalCondition chronic kidney disease / Agenda Introduction Anemia / Anemia / / MedicalTreatment dialysis / / Organization Wayne State University Detroit / Dialysis Oncologic Drugs Advisory Committee / / Person Krishna Polu / Anatole Besarab / Christine Conroy / Anne-Marie Duliege / / Position Hb / Professor / Director of Clinical Research Section / Vice President / / Product Peginesatide Injection / for / Peginesatide / Dialysis / / Technology ESA / Dialysis / /
SocialTag |